Companies/Stayble Therapeutics AB
Follow

Stayble Therapeutics AB

Nasdaq First North GM Stockholm (Sweden)

Stayble Therapeutics is a clinical stage pharmaceutical company developing STA363, an intradiscally injected formulation against chronic discogenic low back pain. The treatment is aimed at patients whose back pain persists after physiotherapy and analgesics.
Go to market

Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Media
Showing 3 of 5
View all
www.staybletherapeutics.com
Rights issue
Price
1.78 SEK
Subscription period
24 Mar - 12 Apr 2023
Subscribe
Please to proceed or
Sign up for FREE
 View Details
Top
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Show archived

NB! Information about past events and all documents are available for signed in users who have bought those events.

Type
Ticker
ISIN
Market
SHARE
STABL
SE0013513652
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Stayble Therapeutics AB with ticker STABL
Status
Active
Currency
SEK
First trading date
09 Mar 2020
Exercise
Sign in to buy
Rights issue
Sign in to buy
Type
Price
Pre-money
Time
Files
Rights issue
1.78 SEK
24.65M SEK
24 Mar - 12 Apr 2023
Share issue in Stayble Therapeutics AB

We have reserved some of the more detailed information for our registered users. Please sign in if You have already registered.

Get access to Events, Instruments, Documents, Media and much more by signing up for FREE!

Partially obscured image showing event data
Sign up for FREE
Type
Ticker
ISIN
Market
SHARE
STABL
SE0013513652
Nasdaq First North GM Stockholm
Sweden (SE)
Details of share in Stayble Therapeutics AB with ticker STABL
Status
Active
Currency
SEK
First trading date
09 Mar 2020
Rights issue
Sign in to buy
Type
Price
Pre-money
Time
Files
Rights issue
1.78 SEK
24.65M SEK
24 Mar - 12 Apr 2023
Share issue in Stayble Therapeutics AB

We have reserved some of the more detailed information for our registered users. Please sign in if You have already registered.

Get access to Events, Instruments, Documents, Media and much more by signing up for FREE!

Partially obscured image showing event data
Sign up for FREE
Type
Ticker
ISIN
Market
OPTION
STABL TO1
SE0013748381
Nasdaq First North GM Stockholm
Sweden (SE)
Details of option in Stayble Therapeutics AB with ticker STABL TO1
Status
Archived
Currency
SEK
Trading period
09 Mar 2020 - 25 Nov 2020
Terms
One (1) warrant entitles the holder to subscribe for one (1) new share in the Company for the the volume-weighted market price during the period from October 30, 2020 - November 13, 2020 with a discount of thirty (30) percent, but not less than SEK 12.30 and not more than SEK 24.60 per share. The subscription with the support of warrant will take place from November 17, 2020 - December 1, 2020.
Update (16.11.2020): The exercise price for the warrants of series TO1 has been set to SEK 12.30.
Update (17.11.2020): The subscription period for the warrants of series TO1 begins today, October 17, 2020.
Exercise
Sign in to buy
People
Andreas Gerward
CEO
Ulf Björklund
Chairman of the board
Kjell Olmarker
Board member
Patrik Sjöstrand
Board member
Jane Laursen
Board member
Pontus Ottosson
Board member
Company Details
Sector
HEALTH CARE
Website
Address
Medicinaregatan 8 A
Zip code
413 90
City/district
Göteborg
Country
Sweden (SE)
Phones
Email
[email protected]
Registration number
559024-8372
LEI code
549300WD23DE1US21868
First trade date
09 Mar 2020
Registration date
01 Sep 2015
Short name
STABL

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More